Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0000950170-24-129454 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | 2024-11-18 | SRPT | Rodino-Klapac Louise | CSO, Head of R, D | F - Tax | $102.89 | -4,558 | 67.6K | -6% | -$469.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | F | D | 4,558 | $102.89 | 67,630 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021. (F2) Amount of Securities Beneficially Owned includes 47 shares purchased under the Company's registered Employee Stock Purchase Plan on August 30, 2024. |